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Permanent central venous catheters (PCVCs) are essen-
tial for patients who require prolonged intravenous
access for the administration of a wide array of agents,
such as chemotherapy, total parenteral nutrition, or
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In patients who require a permanent central venous catheter (PCVC), the usual aim is to put the
catheter tip at the superior vena cava and right atrium (SVC-RA) junction. However, there is no
study regarding how to guide the positioning of the catheter tip when the SVC-RA junction cannot
be identified on chest radiograph. The objectives of this prospective study were: (1) to investigate the
incidence and etiologies of radiographically undetermined SVC-RA junctions in cancer patients
undergoing PCVC implantation; and (2) to evaluate the feasibility, effectiveness and safety of
combined transesophageal echocardiography (TEE) and laryngeal mask airway (LMA) to guide
the positioning of catheters during implantations in patients without this radiographic landmark.
Over a 1-year study period, 83 consecutive patients with oncologic diseases who required implan-
tation of a PCVC in a tertiary center were screened. Their preoperative chest radiographs were
examined by radiologists to identify the presence of the SVC-RA junction. Patients without a radi-
ographically identifiable SVC-RA junction were classified as cancer-related or cancer-unrelated
in terms of etiology. For patients without this landmark, we used TEE with a pediatric biplane
transducer and a LMA under intravenous general anesthesia during PCVC implantation to guide
the positioning of the catheter tip at the SVC-RA junction. We found that in 16% (13/83) of patients,
the SVC-RA junction could not be identified on radiograph. Among the 13 patients, only three (23%)
had cancer-related etiologies. In all of the 13 patients, the LMA was successfully placed after the
TEE transducer was inserted. No episode of air leak from the LMA was found during surgery. All
had the catheter tip positioned in the anatomic SVC-RA junction under TEE guidance. In conclusion,
16% of cancer patients requiring PCVC implantation had no identifiable SVC-RA junction on
chest radiograph and most causes were cancer-unrelated. In patients without a radiographically
identifiable SVC-RA junction, guidance by TEE under LMA general anesthesia is a feasible, safe
and effective management to position a PCVC at the SVC-RA junction.
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other caustic agents. Data indicate that catheter tips
are ideally positioned at the junction of the superior
vena cava and right atrium, which anatomically cor-
relates to the superior border of the crista terminalis
[1,2]. Improper positioning of the catheter too deep in
the right atrium risks cardiac tamponade, while too
proximal in the high superior vena cava or innomi-
nate veins risk vascular perforation, intravascular
thrombosis, and device malfunction [3–5]. Therefore,
it is essential to position the tip of the PCVC accu-
rately at the superior vena cava–right atrium (SVC-RA)
junction.
The position of the SVC-RA junction is most 
commonly determined by chest radiography as the
apex of the concave shadow formed by the super-
imposition of the distal SVC on the RA [6]. However,
determining the border between the SVC and the RA
on a chest radiograph can be challenging, as previously
described in a small case series of oncologic patients
where this radiographic landmark was sometimes
unidentifiable [7]. In addition, there is a discrepancy
between the radiographic SVC-RA junction and the
anatomic SVC-RA junction as verified by magnetic
resonance imaging or transesophageal echocardiog-
raphy (TEE) [1,7,8]. Therefore, in patients undergoing
surgery requiring TEE monitoring, TEE can be used
to guide the positioning of the central venous catheter
with its tip at the SVC-RA junction [2]. Even though
TEE is a moderately invasive modality, a recent study
showed that intravenous sedation combined with
laryngeal mask airway (LMA) can provide both excel-
lent patient comfort and optimal conditions for TEE
examination [9].
To date, in cancer patients undergoing PCVC
implantation, there is little data about the incidence
or etiologies of unidentifiable SVC-RA junction on
chest radiograph, a finding that can make catheter
positioning difficult when the aim is to put the tip at
the SVC-RA junction. In addition, there is no report
regarding the feasibility of using TEE under LMA
general anesthesia to guide the positioning of the
PCVC in these patients.
Thus, the aims of this study were: (1) to determine
the incidence and etiologies of radiographically
unidentifiable SVC-RA junction in cancer patients
requiring PCVC implantation; and (2) to evaluate the
feasibility, effectiveness, and safety of using TEE with
LMA to guide the positioning of these catheters during
implantation.
METHODS
This study was prospectively conducted in the operat-
ing room of Kaohsiung Medical University Hospital,
a tertiary medical center. Written informed consent
was obtained from each patient prior to enrolment in
the study. The hospital’s institutional review board
reviewed and approved this study.
Between August 2002 and July 2003, 87 consecutive
adult cancer patients who underwent PCVC implan-
tation were screened. The flowchart of the study pro-
tocol is summarized in Figure 1. In brief, before
implantation, each patient had a standard upright
chest posteroanterior X-ray with the same radiographic
parameters and the film was examined by two inde-
pendent radiologists to determine whether or not the
SVC-RA junction could be identified. The decision
was made by the consensus of the two radiologists.
The radiographic SVC-RA junction was defined as
the apex of the concave shadow formed by the super-
imposition of the distal SVC on the RA. Only those
patients with unidentifiable radiographic SVC-RA
junctions were enrolled in this study. Patients with
esophageal disease, which is a contraindication to TEE,
were excluded. The etiologies of these cases were then
classified as cancer-related or cancer-unrelated accord-
ing to their radiographs and/or medical records.
In the operating room, patients without identifiable
radiographic SVC-RA junctions underwent PCVC
implantation through the subclavian vein, under intra-
venous general anesthesia. All of the patients received
premedication with intramuscular atropine 0.01mg/kg
and metoclopramide 10 mg. Induction agents were
administered with atracurium 0.25 mg/kg, propofol
2 mg/kg, and lidocaine 0.4 mg/kg. Pre-oxygenation
for 3 minutes was performed by a mask, and then a
7.5/5.5-MHz pediatric biplane transducer (Hewlett-
Packard 2500) was inserted to the mid-esophagus. With
the patient’s head extended, a classic LMA device was
inserted using a laryngoscope-guided technique [10]
by an experienced anesthesiologist. The LMA was then
connected to a mechanical ventilator.
Proper LMA placement was defined as when the
whole or partial vocal cord is visible on viewing from
a fiberoptic bronchoscope (FOB) while the tip of the
FOB is located at the distal aperture of the LMA. The
duration for the insertion of the LMA was recorded.
To ensure that there was no air leak from the LMA, it
was manipulated to avoid audible air leak in the oral
cavity during the ventilation and to show constant end
tidal CO2 plateau waveform during expiration.
After the TEE and LMA were successfully placed,
propofol (6–12 mg/kg/hr) was administered intra-
venously for maintenance and 2% lidocaine (1 mg/kg)
infiltrating anesthesia was given to prevent incision
pain. The operation was then started. The PCVC
implantation was performed as previously described
[11]. In brief, the right or left subclavian vein was cannu-
lated via the infraclavicular area of the anterior chest
wall, just lateral to the midpoint of the clavicle. After
venous access was achieved, a radio-opaque silicone
catheter (single lumen, Delrin®; HDC Corp., Milpitas,
CA, USA) was tunneled into the vessel and advanced
to the SVC-RA junction with the assistance of TEE. To
perform the TEE, two cardiologists experienced in peri-
operative TEE obtained a longitudinal view of the atria
and both vena cavae in order to visualize the SVC-RA
junction. The anatomic SVC-RA junction was defined
by TEE as the superior border of the crista terminalis [2].
As shown in Figure 2, the catheter was recognized
as several parallel, bright, echo-dense lines surround-
ing the darker fluid-filled lumen. The tip was identified
by directly visualizing the end of the venous catheter
and was confirmed by hyperechogenic microbubbles
quickly flowing out of the distal catheter after a rapid
flush of saline.
Satisfactory positioning of a PCVC was defined 
as when the catheter tip is placed 0.5 cm within the 
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Cancer patients before the implantation of a PCVC
A radiographic SVC-RA junction was identified
Starting the implantation of a PCVC
A biplane pediatric TEE transducer was inserted
Starting the implantation of a PCVC
A classic laryngeal mask airway was inserted
with the laryngoscope-guided technique
A radiographic SVC-RA junction could not be identified
Premedication: Intramuscular atropine 0.01 mg/kg and metoclopramide 10mg
Propofol 6–12 mg/kg/hr for IVGA Induction:
1) Propofol 2 mg/kg with
 0.4 mg/kg lidocaine
2) Atracurium 0.125 mg/kg
3) Propofol 1 mg/kg as needed
Mask oxygenation for 3 minutes
Spontaneous breathing with assisted ventilation with 60% O2
Propofol 6–12 mg/kg/hr for IVGA
Figure 1. Flowchart of the study protocol. PCVC = permanent central venous catheter; SVC-RA = superior vena cava–right atrium;
IVGA = intravenous general anesthesia; TEE = transesophageal echocardiography.
LA
Cath
CT
RA
SVC
Figure 2. A central venous catheter advanced in the superior vena
cava–right atrium (SVC-RA) junction shown on transesophageal
echocardiography. The catheter (Cath) was advanced near the
SVC-RA junction, as defined by the superior border of the crista
terminalis (CT) in the right atrium (RA). LA = left atrium.
TEE-defined SVC-RA junction. After the final position
of the catheter tip was adjusted to the TEE-defined
SVC-RA junction, a post-insertion portable chest X-ray
was taken to exclude pneumothorax or kinking of the
catheter.
RESULTS
Among the 87 patients requiring PCVC implantation,
there were 13 (16%) patients whose radiographic SVC-
RA junctions were unidentifiable. The demographic
data and etiologies of unidentifiable radiographic
SVC-RA junction of these 13 patients are shown in
the Table. In three patients, the etiologies were cancer-
related, while in 10 patients the etiologies were cancer-
unrelated. Some of the radiographs of these patients
are shown in Figure 3.
In all of the 13 patients, the catheter tip was success-
fully placed 0.5cm within the SVC-RA junction under
TEE guidance. Proper placement of the LMA, verified
by FOB, was achieved in all of the patients. The dura-
tion of inserting the LMA was 11 ± 3 seconds. In one
patient, audible air leak in the oral cavity was found
initially after insertion, but resolved after the posi-
tions of the LMA and the patient’s head were adjusted.
During PCVC implantations, no patient had air leak
from the LMA.
DISCUSSION
In this study, we found that 16% of cancer patients
requiring the implantation of a PCVC had SVC-RA
junctions that could not be identified on radiographs,
mostly due to cancer-unrelated causes. In addition, our
study indicates that in patients without this landmark,
TEE guidance combined with LMA under intravenous
general anesthesia is a feasible, safe and effective tech-
nique to achieve the goal of putting the catheter tip at
the SVC-RA junction. To our knowledge, this is the first
report of PCVC implantation in patients with radi-
ographically unidentifiable SVC-RA junctions.
Interestingly, we found that most of the etiologies
of radiographically unidentifiable SVC-RA junctions
were not caused by cancer even though they were all
oncologic patients. This finding is important because
there are possibly many more non-oncologic patients
with radiographically unidentifiable SVC-RAjunctions.
In other words, these results can be extrapolated to
non-oncologic patients with chronic diseases, such as
hemophilia [12], sickle cell disease [13], cystic fibrosis
[14], or short-bowel syndrome [15], since PCVC
implantation is often indicated in these patients due
to their need for repetitive blood transfusion, prolonged
antibiotics, or long-term parenteral nutrition.
To date, there are many methods used to position
the tip of a PCVC at the SVC-RA junction. By conven-
tion, radiography is the most commonly used modality.
In patients without an identifiable SVC-RA junction
on chest radiograph, fluoroscopy may be an alternative
to identify this landmark. However, many recent stud-
ies indicate the discrepancy between the anatomic and
radiographic SVC-RA junction [1,7]. Aslamy et al [8]
utilized magnetic resonance imaging and found that
the right upper cardiac silhouette was in fact delineated
by the left atrium in 38% of patients. Accordingly, the
location of the SVC-RA junction shown on fluoroscopy
can probably be misleading due to the confounding
effect of the contour of the overlapping image of the left
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Table. Demographics of the 13 patients with unidentifi-
able superior vena cava–right atrium (SVC-RA) junction
on chest radiograph*
Gender (M/F) 7/6
Age (yr) 51 ± 12
Weight (kg) 65 ± 9
Height (cm) 162 ± 14
Diagnosis 13
Gastric cancer 2
Lung cancer 2
Breast cancer 2
Colon cancer 2
Liver tumor 2
Pancreatic cancer 2
Pheochromocytoma 1
Etiologies of unidentifiable SVC-RA
junction in the radiograph
Cancer-related 3
Malignant pleural effusion 2
Pulmonary metastasis 1
Cancer-unrelated 10
Dilated or tortuous aorta 3
Elevation of right diaphragm 2
Emphysema 1
Engorged SVC 1
Fibrothorax 1
Scoliosis 1
Pneumonia 1
*Data are presented as mean ± standard deviation or n.
atrium. Furthermore, fluoroscopy has the disadvantage
of high radiation exposure to patients.
Aside from fluoroscopy, other techniques used to
identify landmarks of the SVC-RAjunction include skin
surface landmark or vertebrae body. However, our
previous study has shown that they are both unreliable
references [7,11]. Another technique, intravenous
electrocardiography, has also been shown to be a reli-
able method for guiding the position of the catheter tip
in the anatomic SVC-RA junction [11]. However, this
technique is not available in every hospital and some
expertise is required to interpret the results.
On the other hand, TEE has been used as a stan-
dard choice for guiding the placement of a central
catheter tip to the SVC-RA junction in patients dur-
ing cardiac operations [1,16] because it can accurately
reveal the dimensional relation between the catheter
tip and the anatomic SVC-RA junction in a real-time
manner. However, the role of TEE in guiding catheter
tip placement in patients without cardiac disease
remains to be studied. In our institution, we rou-
tinely perform the implantation of a PCVC under
intravenous general anesthesia to alleviate the anxi-
ety and pain response in cancer patients.
Radiographically unidentifiable SVC-RA junctions
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Figure 3. Perioperative chest radiographs in two patients without radiographic superior vena cava–right atrium (SVC-RA) junctions.
(A) The preoperative radiograph of a patient with tortuous ascending aorta (arrow) that blunted the SVC-RA junction. (B) The postopera-
tive radiograph of the same patient after implantation of a permanent central venous catheter. (C) The preoperative radiograph of a patient
with gastric cancer and diffuse pulmonary metastasis (arrow) that blunted the SVC-RA junction. (D) The postoperative radiograph of the
same patient.
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In this study, because of the potential side effect of
TEE on airway obstruction, we simultaneously used
LMA, a relatively noninvasive device compared to
endotracheal tube, to establish a patent airway for
mechanical ventilation during implantation surgery.
In addition, we used a pediatric biplane transducer to
reduce the side effect of TEE because of its shorter
diameter. With this smaller transducer, we still achieved
precise viewing of the SVC-RAjunction and catheters in
adults, even without multiplane function. Ferson et al
[9] has recently shown that by the support of LMA
under propofol infusion, it is safe to perform TEE in an
outpatient cardiology clinic setting with an adult trans-
ducer. Therefore, it is not surprising that in our study,
with continuous monitoring of cardiopulmonary func-
tion in the operating room, this technique with the com-
bination of TEE and LMA is also safe and effective.
The most important advantage of using TEE to
guide the positioning of the catheter tip is that it can
accurately guide the tip to the anatomic SVC-RA junc-
tion rather than to the radiographic SVC-RA junction.
This can potentially reduce the risk of cardiac tampon-
ade when the catheter tip is too deep [6], or device mal-
function when it is too high [5]. In addition, it can
reduce the radiation exposure to patients, since Fricke
et al [17] reported that 86% of patients receiving periph-
erally inserted central catheter without fluoroscopy
guidance required additional manipulation by fluoro-
scopy to achieve a proper position of the catheter tips.
The primary limitation of this study is the sample
size. Larger studies are warranted to validate the role
of this combined TEE and LMA technique in patients
requiring a PCVC, both in oncologic patients and
non-oncologic patients. Another limitation is the lack
of a control group. However, since there were no radi-
ographic SVC-RA junctions in these patients, we could
not use the conventional radiographic method as the
control group in the present study.
In conclusion, our study indicates that in cancer
patients with radiographically unidentifiable SVC-RA
junctions, the novel technique of combined TEE and
LMA is a feasible, safe and effective method to guide
the catheter tip of a PCVC to the SVC-RA junction.
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